A decade on from the launch of an ambitious project, it’s time to revisit the reasons for constructing a human genome from ...

The technology can whip up spurious findings and pollute survey responses, but it could also make research more rigorous.

Diseases are likely to emerge in regions such as Ituri that are weakened by overlapping crises, political instability and ...

Newly found immune cells called ‘ruptoblasts’ explode when triggered, ejecting toxic chemicals capable of delivering death to surrounding cells in just minutes. The cells’ discoverers say that this ...

A 53-year-old clinically dead man has become the first person to receive two kidneys and a whole liver from a genetically ...

Treatments aim to bulk up failing hearts to restore their vigour – but can the field move on from past controversy?

Bad experiences with supervisors are common among early-career researchers and one of the leading reasons they leave academia, a survey of more than 2,600 researchers has found 1. The study, which was ...

An experiment with 2,520 participants backs Richard Feynman’s answer to every diner’s dilemma: do I want to try something new? In a scene that could have easily featured in an episode of the US ...

The landmark success of a drug against an ‘undruggable’ cancer is spurring fresh optimism in the quest to treat seemingly untouchable tumour targets. The experimental drug, daraxonrasib, disarms all ...

Public-health researcher James Baguma has studied the interactions between bats, which can carry the virus, and people in the ...